Taking a 360° view on the exciting new developments in the field of Theranostics and Radiomolecular Precision Medicine (RPM).
See our e-poster, “Antibody fragments for radiopharmaceutical therapy of solid tumors: Dosimetry studies using 177 Lu radiolabeled minibodies”.
Connect with Gareth Smith, our VP, Business Strategy by scheduling a meeting.